Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 16;12(1):8543.
doi: 10.4081/idr.2020.8543. eCollection 2020 Feb 25.

National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management

Emanuele Nicastri  1 , Nicola Petrosillo  1 , Tommaso Ascoli Bartoli  1 , Luciana Lepore  1 , Annalisa Mondi  1 , Fabrizio Palmieri  1 , Gianpiero D'Offizi  1 , Luisa Marchioni  1 , Silvia Murachelli  1 , Giuseppe Ippolito  1 , Andrea Antinori  1
Affiliations

National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management

Emanuele Nicastri et al. Infect Dis Rep. .

Abstract

On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data.

Keywords: COVID-19; SARS-CoV-2; Treatment.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors declare no potential conflict of interest.

References

    1. European Centre for Disease Prevention and Control. Rapid Risk Assessment: Novel coronavirus disease 2019 (COVID-2019) pandemic: increased transmission in the EU/EEA – sixth update. ECDC: Stockholm;. 2020, 12 March 2020 Available at: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-sixth-updat...
    1. Ministero della Salute. Direzione Generale della Prevenzione Sanitaria. Ufficio 5: Prevenzione delle Malattie Trasmissibili e Profilassi Internazionale. Aggiornamento Circolare 09.03.2020. Allegato 1. Definizione di caso di COVID-19 per la segnalazione. Available at http://www.salute.gov.it/portale/documentazione/p6_2_6.jsp?lingua=italia..., visited on March 13 2020.
    1. WHO. Global Surveillance for human infection with coronavirus disease (COVID-2019). Revised guidance, 27 February 2020. Available at https://www.who.int/publications-detail/global-surveillance-for-human-in..., visited on 28 February 2020.
    1. European Centre for Disease Prevention and Control. An agency of the European Union. Case definition for EU surveillance of COVID-19, as of 25 February 2020. Available at https://www.ecdc.europa.eu/en/case-definition-and-european-surveillance-..., visited on 28 February 2020.
    1. Centers for Disease Control and Prevention (CDC). Interim Infection Prevention and Control Recommendations for Patients with Confirmed Coronavirus Disease 2019 (COVID-19) or Persons Under Investigation for COVID-19 in Healthcare Settings. Updated February 21, 2020. Available at https://www.cdc.gov/coronavirus/2019-ncov/infectioncontrol/control-recom..., visited on February 28 2020.

LinkOut - more resources